💡 What You Need to Know Right Away
- Senolytics can clear senescent cells in humans: The combination of dasatinib and quercetin significantly reduced senescent cell markers in human adipose tissue within just 2 weeks, representing the first peer-reviewed evidence that senolytics work in humans.[Evidence: B][3]
- Fisetin emerged as the most potent natural senolytic: Among 10 flavonoids tested, fisetin demonstrated the strongest senolytic activity and extended both median and maximum lifespan in mouse models.[Evidence: A][4]
- Spermidine is essential for fasting's longevity benefits: Research shows blocking spermidine completely eliminated the lifespan-extending effects of fasting, revealing the polyamine-hypusination axis as conserved across species.[Evidence: A][10]
- Senescent cell accumulation increases with age: A systematic review and meta-analysis confirmed that senescence markers are higher in aged human tissues, though the magnitude varies by tissue type, location, and detection method.[Evidence: A][13]
It is common to feel confused when you first encounter the paradox of apoptosis and aging. How can cell death possibly be good for longevity? This is the question driving some of the most promising anti-aging research today.
Apoptosis, or programmed cell death, is your body's natural quality control system. It removes damaged, dysfunctional, or potentially dangerous cells before they cause harm. Yet as we age, this process becomes dysregulated. Some cells that should die become resistant (accumulating as senescent "zombie cells"), while others die too readily (causing tissue loss).
This guide examines 16 peer-reviewed studies to help you understand how apoptosis affects longevity, why senescent cells resist death, and what science says about interventions like senolytics, fasting, and natural compounds. You will learn the mechanisms, the evidence, the risks, and practical strategies backed by clinical research.
❓ Quick Answers
What is the relationship between apoptosis and aging?
Apoptosis plays a dual role in aging. Properly regulated apoptosis removes damaged cells and supports tissue health. However, aging causes dysregulation: senescent cells develop resistance to apoptosis and accumulate, while post-mitotic tissues like neurons and heart muscle may experience excessive cell death. Research shows senescent cells resist normal cell death through upregulation of anti-apoptotic pathways.[Evidence: C][1]
How does apoptosis affect lifespan?
The relationship depends on tissue type and context. In mouse studies, fisetin, the most potent senolytic among 10 flavonoids tested, extended both median and maximum lifespan by inducing apoptosis in senescent cells.[Evidence: A][4] Senolytics that promote selective apoptosis in damaged cells show promise for healthspan extension.
What is the difference between apoptosis and autophagy?
Apoptosis is programmed cell death that eliminates entire cells. Autophagy is cellular "self-eating" that recycles damaged components while keeping the cell alive. Both processes support longevity through different mechanisms. Research demonstrates spermidine is essential for fasting-mediated autophagy and lifespan extension, with the polyamine-hypusination axis conserved across species.[Evidence: A][10]
Why are senescent cells resistant to apoptosis?
Senescent cells upregulate anti-apoptotic proteins in the BCL-2 family and develop Senescent Cell Anti-apoptotic Pathways (SCAPs). Research indicates different senescent cells rely on different survival mechanisms, which is why senolytics target these specific pathways to overcome resistance.[Evidence: C][1]
What are senolytics and how do they target apoptosis?
Senolytics are compounds that selectively induce apoptosis in senescent cells. The combination of dasatinib and quercetin significantly reduced senescent cell markers in human adipose tissue, providing the first peer-reviewed evidence that senolytics work in humans.[Evidence: B][3] These compounds target survival pathways that senescent cells depend on.
Can exercise and fasting affect apoptosis?
Yes. Fasting activates autophagy and can influence apoptotic pathways. Research shows spermidine is essential for fasting-mediated autophagy. Blocking spermidine eliminated the lifespan benefits from fasting in multiple species.[Evidence: A][10] Caloric restriction combined with senolytics enhanced benefits in primate studies.[Evidence: B][11]
How does p53 regulate apoptosis in aging?
The p53 protein acts as a master regulator of apoptosis, activating cell death pathways when cells are damaged. Research on curcumin shows it has pro-apoptotic effects in cancer cells via p53 upregulation, demonstrating how this pathway can be therapeutically targeted.[Evidence: D][8] Age-related decline in p53 function may contribute to both cancer risk and cellular dysfunction.
Apoptosis & Longevity
Discover how programmed cell death—the body's natural "sculpting" process—is the secret key to preventing disease and extending human healthspan.
🔬 How Does Apoptosis Work in Aging?
Think of apoptosis as your body's quality control department. Just as a factory removes defective products before they reach customers, your cells have built-in self-destruct mechanisms that eliminate damaged or dangerous cells before they cause harm. This "programmed cell death" is essential for healthy development and tissue maintenance throughout life.
The process works through two main pathways:
The intrinsic (mitochondrial) pathway activates when cells detect internal damage. Stress signals cause mitochondria to release cytochrome c, triggering a cascade of enzymes called caspases that systematically dismantle the cell. This is like a building's internal fire suppression system, activating from within when danger is detected.
The extrinsic (death receptor) pathway responds to external signals from other cells, similar to receiving a demolition order from outside authorities.
Why Apoptosis Becomes Dysregulated with Age
As we age, this quality control system breaks down in opposing directions depending on the tissue:
In mitotic tissues (cells that continue dividing), damaged cells often become resistant to apoptosis. Research demonstrates that senescent cells resist normal cell death through multiple mechanisms, and different senescent cell types rely on different survival pathways.[Evidence: C][1] A systematic review and meta-analysis confirmed that senescence markers are higher in aged human tissues, though the magnitude varies by tissue type, location, and detection method.[Evidence: A][13]
In post-mitotic tissues (non-dividing cells like neurons and heart muscle), excessive apoptosis can lead to tissue loss and functional decline.
How Senolytics Restore Apoptosis
Senolytic compounds work by targeting the survival pathways that senescent cells depend on. Among 10 flavonoids tested, fisetin demonstrated the most potent senolytic activity using a "hit-and-run" mechanism.[Evidence: A][4] Preclinical data shows senolytics have promise in heart failure and post-infarction recovery.[Evidence: D][6]
Natural Compounds and Apoptosis Pathways
Several natural compounds modulate apoptosis-related pathways:
- Resveratrol acts as a calorie restriction mimetic via SIRT1 activation. SIRT1 overexpression extends lifespan across multiple species.[Evidence: D][7]
- Curcumin modulates AMPK, AKT/mTOR, and NF-κB pathways, with pro-apoptotic effects in cancer cells via p53 upregulation.[Evidence: D][8]
- EGCG (from green tea) promotes cytotoxic autophagy via PI3K/Akt/mTOR inactivation and synergizes with chemotherapy.[Evidence: D][9]
- Spermidine is essential for fasting-mediated autophagy and lifespan extension through the polyamine-hypusination axis.[Evidence: A][10]
In primate studies, dasatinib plus quercetin reduced senescence markers in adipose tissue and improved immune function and metabolic outcomes.[Evidence: B][11]
📊 Senolytic Dosage and Clinical Protocols
The following dosages come from peer-reviewed clinical trials studying senolytic interventions in humans. These are research protocols, not recommendations. Always consult a healthcare provider before considering any intervention.
| Condition/Purpose | Compounds | Dosage | Duration | Evidence |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Dasatinib + Quercetin | 100 mg D + 1250 mg Q | 3 weeks | [B][2] |
| Diabetic Kidney Disease | Dasatinib + Quercetin | 100 mg D + 1000 mg Q daily | 3 days | [B][3] |
| Bone Metabolism (Postmenopausal) | Dasatinib + Quercetin | 100 mg D + 1000 mg Q intermittent | 20 weeks | [B][14] |
| Alzheimer's Disease (Feasibility) | Dasatinib + Quercetin | 100 mg D + 1250 mg Q every 2 weeks | 12 weeks | [B][15] |
| Biological Aging Reduction | Fisetin | 500 mg daily for 1 week monthly | 6 months | [D][5] |
Key Protocol Insights
Hit-and-run approach: Most protocols use intermittent dosing rather than continuous treatment. The D+Q protocol reduced senescent burden within 2 weeks using this approach.[Evidence: B][3]
Primate data: In nonhuman primates, D+Q reduced senescence markers in adipose tissue and combined with caloric restriction to enhance benefits.[Evidence: B][11]
Muscle function: In aging mice, intermittent fisetin mitigated frailty and grip strength decline, with efficacy comparable to genetic senescent cell clearance and pharmaceutical approaches. It also reduced senescence markers Cdkn1a and Ddit4.[Evidence: B][12]
CNS penetrance: In the Alzheimer's feasibility trial, dasatinib was detected in cerebrospinal fluid in 4 of 5 participants (80%), indicating the compound can cross the blood-brain barrier.[Evidence: B][15]
⚠️ Risks, Side Effects, and Warnings
⚠️ Important Safety Information
- Dasatinib is an FDA-approved prescription medication for cancer. Using it off-label for anti-aging purposes requires medical supervision.
- All clinical trials reported no serious adverse events attributed to D+Q treatment.[2][14][15]
- Quercetin may interact with certain medications. Consult your healthcare provider before use.
- Senolytic research is in early phases. Long-term safety data beyond 20 weeks is not established.
Side Effects from Clinical Trials
In the IPF Phase I trial, the D+Q combination was feasible and well-tolerated, with no serious adverse events attributed to treatment.[Evidence: B][2]
In the bone metabolism Phase 2 RCT, there were no serious adverse events reported. Women with high senescent cell burden saw 2.7% bone density increase at the radius, while overall results showed no significant difference in bone resorption.[Evidence: B][14]
In the Alzheimer's feasibility trial, treatment was well-tolerated with no early discontinuation. All 5 participants completed the 12-week study.[Evidence: B][15]
In the fisetin pilot study, no adverse effects were reported across the 6-month protocol.[Evidence: D][5]
When Apoptosis Causes Harm
Excessive apoptosis in post-mitotic tissues contributes to age-related conditions:
- Sarcopenia: Research shows fisetin mitigated frailty and grip strength decline in aging mice, suggesting excess apoptosis contributes to muscle loss.[Evidence: B][12]
- Neurodegeneration: While senolytics show CNS penetrance, the effects on neuronal apoptosis require further study.
- Cardiac function: Preclinical data suggest senolytics show promise in heart failure and post-infarction recovery, but human trials are needed.[Evidence: D][6]
Contraindications
Based on available evidence:
- Pregnancy and breastfeeding: No reproductive safety studies found. Avoid senolytic protocols without medical supervision.
- Pediatric use: No pediatric studies exist. Field is focused on aging adults.
- Immunocompromised individuals: Senescent cells play complex roles in immune function. Consult a healthcare provider.
Monitoring Recommendations
Clinical trials did not establish specific monitoring protocols for general use. If considering senolytic interventions under medical supervision, baseline health assessment is recommended.
🥗 Practical Ways to Support Healthy Cellular Aging
Evidence-Based Approaches
Approach 1: Fasting and Autophagy
- Mechanism: Spermidine is essential for fasting-mediated autophagy and lifespan extension. Blocking spermidine eliminated lifespan benefits from fasting.[Evidence: A][10]
- Integration: The polyamine-hypusination axis is conserved across species, suggesting fasting benefits are fundamental to cellular biology.
- Practical approach: Intermittent fasting may support autophagy. Consult a healthcare provider before starting any fasting protocol, especially if you have underlying health conditions.
Approach 2: Caloric Restriction Combined with Senolytics
- Evidence: In primate studies, D+Q combined with caloric restriction enhanced benefits for immune function and metabolic outcomes.[Evidence: B][11]
- Outcome: D+Q reduced senescence markers in adipose tissue and improved metabolic outcomes.
- Timeline: Primate studies provide long-term data supporting continued investigation in humans.
Approach 3: Senolytic Protocols Under Medical Supervision
- First human evidence: D+Q significantly reduced senescent cell markers in human adipose tissue using a hit-and-run treatment that reduced senescent burden within 2 weeks.[Evidence: B][3]
- Protocol: 100 mg dasatinib + 1000 mg quercetin daily for 3 days
- Important: This is a research protocol. Dasatinib is a prescription medication requiring medical oversight.
Approach 4: Natural Senolytic Compounds
- Fisetin: Most potent senolytic among 10 flavonoids tested. Extended median and maximum lifespan in mice using hit-and-run mechanism.[Evidence: A][4]
- Fisetin in mice: Intermittent supplementation mitigated frailty and grip strength decline in aging mice, with efficacy comparable to genetic and pharmaceutical approaches.[Evidence: B][12]
- Human pilot: 500 mg fisetin monthly for 6 months showed mixed results (4/10 adults reduced biological aging, 5/10 increased), with no adverse effects.[Evidence: D][5]
Common Mistakes to Avoid
- Expecting immediate results: Hit-and-run senolytic protocols work over weeks to months, not days.
- Continuous dosing: Research protocols use intermittent dosing. Continuous high-dose supplementation has not been studied for safety.
- Self-prescribing dasatinib: This is a prescription cancer medication with potential side effects requiring medical supervision.
⚖️ Apoptosis vs. Autophagy: Understanding the Difference
Both apoptosis and autophagy are cellular quality control mechanisms that support healthy aging, but they work through fundamentally different approaches.
| Feature | Apoptosis | Autophagy |
|---|---|---|
| Definition | Programmed cell death | Cellular "self-eating" and recycling |
| Outcome | Entire cell is eliminated | Cell survives; damaged parts recycled |
| Primary Trigger | Severe damage, senescence, cancer risk | Nutrient deprivation, mild stress |
| Key Activator | Caspases, BCL-2 family | mTOR inhibition, AMPK activation |
| Fasting Effect | Indirect via senolytic pathways | Direct activation; spermidine essential[10] |
| Therapeutic Target | Senolytics (D+Q, fisetin) | Caloric restriction, spermidine |
How They Work Together
Autophagy and apoptosis are complementary. When autophagy successfully repairs cellular damage, apoptosis is prevented. When damage exceeds autophagy's capacity, apoptosis eliminates the compromised cell.
Research on EGCG demonstrates this connection: it promotes cytotoxic autophagy via PI3K/Akt/mTOR inactivation.[Evidence: D][9]
Natural Compounds Affecting Both Pathways
| Compound | Apoptosis Effect | Autophagy Effect | Evidence |
|---|---|---|---|
| Fisetin | Most potent senolytic tested | Indirect via mTOR | [A][4] |
| Quercetin | Senolytic in combination with D | mTOR modulation | [B][3] |
| Resveratrol | CR mimetic via SIRT1 | SIRT1-dependent autophagy | [D][7] |
| Curcumin | Pro-apoptotic in cancer via p53 | AMPK, mTOR modulation | [D][8] |
| EGCG | Pro-oxidant activity | Cytotoxic autophagy activation | [D][9] |
| Spermidine | Indirect effects | Essential for fasting-mediated autophagy | [A][10] |
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- Senolytics can reduce senescent cells in humans: D+Q significantly reduced senescent cell markers in human adipose tissue within 2 weeks, the first peer-reviewed human evidence.[Evidence: B][3]
- Fisetin extends lifespan in animal models: Among 10 flavonoids tested, fisetin was the most potent senolytic and extended median and maximum lifespan in mice.[Evidence: A][4]
- Spermidine is essential for fasting benefits: Blocking spermidine eliminated the lifespan benefits from fasting, with the polyamine-hypusination axis conserved across species.[Evidence: A][10]
- Senescence increases with age across tissues: Meta-analysis confirmed higher senescence markers in aged human tissues, though magnitude varies by tissue type and detection method.[Evidence: A][13]
- Senolytics can penetrate the CNS: Dasatinib was detected in cerebrospinal fluid in 80% of participants in the Alzheimer's feasibility trial.[Evidence: B][15]
What's NOT Yet Proven
- Long-term safety: No trials exceed 20 weeks. Long-term effects of senolytic protocols in humans remain unknown.
- Optimal dosing: Studies used varying doses (D: 100mg; Q: 1000-1250mg). Optimal human dosing not established.
- Lifespan extension in humans: Animal data is promising, but no human longevity trials completed.
- Pregnancy and pediatric safety: No reproductive or pediatric studies exist. These populations should avoid senolytic protocols.
- Fisetin optimal protocol: Pilot study showed mixed results (4/10 improved, 5/10 worsened). Human protocols need refinement.[Evidence: D][5]
Where Caution Is Needed
- Dasatinib is a prescription cancer drug: Off-label use requires medical supervision and carries risks.
- Individual variation: Benefits appeared in women with high senescent cell burden, not the general population.[Evidence: B][14]
- Cognitive endpoints unclear: Secondary cognitive endpoints did not significantly differ in the Alzheimer's trial.[Evidence: B][15]
- Supplement quality varies: Commercial fisetin and quercetin products are not standardized like research compounds.
Should YOU Try This?
Best suited for: Adults interested in emerging longevity research who understand these are early-phase findings. Those with high senescent cell burden (possibly indicated by age-related conditions) may see more benefit based on the bone metabolism trial subgroup analysis.[Evidence: B][14]
Not recommended for: Pregnant or breastfeeding women, children, immunocompromised individuals, those on medications without medical guidance, and anyone expecting immediate anti-aging results.
Realistic timeline: Clinical trials show effects within 2-20 weeks depending on protocol and outcome measured. Individual response varies.
When to consult a professional: Before starting any senolytic protocol, especially if considering dasatinib (prescription required), if taking other medications, or if you have underlying health conditions.
Frequently Asked Questions
Does increasing apoptosis extend longevity?
The answer depends on which cells undergo apoptosis. Selective induction of apoptosis in senescent cells appears beneficial. Fisetin, the most potent senolytic among 10 flavonoids tested, extended both median and maximum lifespan in mice using a hit-and-run mechanism that eliminates senescent cells while sparing healthy ones. However, excessive apoptosis in healthy tissues (neurons, muscle, heart) contributes to age-related decline. The key is selective targeting of damaged cells while protecting functional tissue.
What role do mitochondria play in apoptosis and aging?
Mitochondria are central to the intrinsic apoptosis pathway. When cells are damaged, mitochondria release cytochrome c, triggering caspase activation and cell death. Age-related mitochondrial dysfunction can dysregulate this process. Research shows compounds like curcumin modulate AMPK, AKT/mTOR, and NF-κB pathways that interact with mitochondrial function. EGCG promotes effects via PI3K/Akt/mTOR inactivation, which influences mitochondrial-related cellular processes.
What foods or supplements affect apoptosis?
Several natural compounds modulate apoptosis pathways. Fisetin, found in strawberries and apples, emerged as the most potent senolytic among 10 flavonoids tested. Quercetin (onions, apples) works synergistically with dasatinib in senolytic protocols. Resveratrol (red wine, grapes) acts as a calorie restriction mimetic via SIRT1. Curcumin and EGCG affect multiple pathways. However, dietary amounts differ significantly from research doses, and bioavailability is limited.
Is too much apoptosis bad for aging?
Yes, in certain tissues. Excessive apoptosis in post-mitotic cells (neurons, cardiac myocytes, muscle fibers) contributes to sarcopenia, neurodegeneration, and heart dysfunction. Research shows fisetin mitigated frailty and grip strength decline in aging mice, suggesting that addressing excessive apoptosis in muscle tissue may help preserve function. The goal is balance: promoting apoptosis in senescent cells while protecting healthy functional tissue.
How is apoptosis measured in aging research?
Researchers use several biomarkers and assays. The systematic review and meta-analysis on cellular senescence found that senescence markers are higher in aged tissues, but the magnitude varies by tissue type, location, and detection method used. Common markers include senescence-associated proteins (p16, p21), SASP factors, and caspase activity. In the muscle study, researchers measured senescence markers Cdkn1a and Ddit4. These are research tools, not consumer tests.
Can targeting apoptosis slow aging?
Emerging evidence supports this possibility. D+Q significantly reduced senescent cell markers in human adipose tissue within 2 weeks, providing the first peer-reviewed evidence that senolytics work in humans. Senolytics show promise in heart failure and post-infarction recovery, with early-phase trials providing rationale for cardiovascular studies. However, most data comes from animal studies and early-phase human trials. Large-scale longevity studies are not yet completed.
How long does it take for senolytic interventions to work?
The hit-and-run approach used in clinical trials shows effects within weeks. D+Q reduced senescent burden within 2 weeks in humans. In the bone metabolism study, benefits in women with high senescent cell burden (2.7% bone density increase at radius) were observed over 20 weeks. The Alzheimer's feasibility study ran 12 weeks with dasatinib detected in CSF in 80% of participants. Individual response and timeline vary by condition and senescent cell burden.
Should I take senolytic supplements?
This is a personal decision requiring medical guidance. The fisetin pilot study showed mixed results: 4 of 10 adults reduced biological aging while 5 of 10 increased, with no adverse effects. A 2025 pilot study found reductions in TNF-α correlated with cognitive score increases, but data is preliminary due to lack of control group. Fisetin and quercetin are available as supplements. Dasatinib requires prescription. Consult a healthcare provider before starting any senolytic protocol.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development. Hu L, et al. Frontiers in Cell and Developmental Biology, 2022. DOI PubMed [Evidence: C]
- 2 . Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial. Nambiar A, et al. EBioMedicine, 2023. DOI PubMed [Evidence: B]
- 3 . Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. Hickson LJ, et al. EBioMedicine, 2019. DOI PubMed [Evidence: B]
- 4 . Fisetin is a senotherapeutic that extends health and lifespan. Yousefzadeh MJ, et al. EBioMedicine, 2018. DOI PubMed [Evidence: A]
- 5 . The Effects of Fisetin on Reducing Biological Aging: A Pilot Study. Lee E, Burns M. Alternative Therapies in Health and Medicine, 2024. PubMed [Evidence: D]
- 6 . Senolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunction. Atlante S, et al. European Journal of Internal Medicine, 2025. DOI PubMed [Evidence: D]
- 7 . SIRT1, resveratrol and aging. Rogina B, Tissenbaum HA. Frontiers in Genetics, 2024. DOI PubMed [Evidence: D]
- 8 . The beneficial effects of curcumin on aging and age-related diseases. He Y, et al. Frontiers in Aging Neuroscience, 2025. DOI PubMed [Evidence: D]
- 9 . The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment. Ferrari E, et al. International Journal of Molecular Sciences, 2022. DOI PubMed [Evidence: D]
- 10 . Spermidine is essential for fasting-mediated autophagy and longevity. Hofer SJ, et al. Nature Cell Biology, 2024. DOI PubMed [Evidence: A]
- 11 . Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates. Ruggiero AD, et al. Geroscience, 2023. DOI PubMed [Evidence: B]
- 12 . Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging. Murray KO, et al. Aging Cell, 2025. DOI PubMed [Evidence: B]
- 13 . Cellular senescence and chronological age in various human tissues: A systematic review and meta-analysis. Tuttle CSL, et al. Aging Cell, 2020. DOI PubMed [Evidence: A]
- 14 . Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Farr JN, et al. Nature Medicine, 2024. DOI PubMed [Evidence: B]
- 15 . Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Gonzales MM, et al. Nature Medicine, 2023. DOI PubMed [Evidence: B]
- 16 . A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease. Millar CL, et al. EBioMedicine, 2025. DOI PubMed [Evidence: D]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
